CopyFind
Metosartan 50 Tablet ER
medicine 📍 IN

Metosartan 50 Tablet ER

201,00 ₹

Analogs of Metosartan 50 Tablet ER

Find cheaper analogs and generic equivalents for Metosartan 50 Tablet ER.

Ingredients

活性成分: Telmisartan; Metoprolol Succinate


产品概览

About Metosartan 50 Tablet ER

Metosartan 50 Tablet ER is a medication containing the active ingredient Telmisartan, classified as Blood pressure medication. Telmisartan, sold under the brand name Micardis among others, is a medication used to treat high blood pressure and heart failure. It is a reasonable initial treatment for high blood pressure.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower.
  • Used for: Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Telmisartan, the active ingredient in Metosartan 50 Tablet ER, belongs to the Blood pressure medication class. 1 INDICATIONS AND USAGE Telmisartan tablets, USP are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Metosartan 50 Tablet ER. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Metosartan 50 Tablet ER for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Metosartan 50 Tablet ER.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.